IABDM Supports White House Appeal To End Dental Mercury And Investigate Casa Pia Trial


Date:

(MENAFN- EIN Presswire)

IABDM supports a formal White House appeal calling for an end to new mercury dental fillings, stronger removal safety standards, and an independent investigation of the NIH-funded Casa Pia children's dental trial in Portugal.

IABDM calls for an end to new mercury fillings, safer removal standards, and an independent investigation of the NIH-funded Casa Pia children's trial.

ROUND ROCK, TX, UNITED STATES, November 16, 2026 /EINPresswire / -- The International Academy of Biological Dentistry and Medicine (IABDM) announces its support for a formal appeal submitted to President Donald Trump by international mercury advocate Anita Tibau, calling for an end to new mercury dental amalgam placements, national removal safety standards, and an independent investigation of the NIH-funded Casa Pia children's dental trial in Portugal.

According to Tibau, the White House has acknowledged receipt of her appeal.

The Casa Pia Children's Trial

The NIH-funded study (U01 DE011894) enrolled 507 children in Lisbon, Portugal, comparing mercury-containing dental amalgam with composite fillings.

In 2002, widespread allegations of sexual abuse involving children at Casa Pia became public. The dental trial continued afterward, raising questions among advocates about research oversight and protections for vulnerable participants.

Tibau obtained documents through the Freedom of Information Act (FOIA), including a September 15, 1999, Data and Safety Monitoring Board report. She contends that the report documented sentinel events and mercury-related observations inadequately addressed in subsequent publications.

The 2006 study published in JAMA reported no statistically significant differences in its principal measured neurobehavioral outcomes between treatment groups. Tibau is calling for an independent examination of the complete research and safety records.

The investigation seeks to determine whether appropriate safeguards were maintained and whether federal regulators received complete safety information.

Four Federal Actions Supported by IABDM

1. End New Mercury Dental Amalgam Placements

Direct HHS and FDA to pursue the fastest lawful pathway to end routine new mercury amalgam placements nationwide, coordinating with CMS, the Indian Health Service, Veterans Affairs, and other federal healthcare programs.

2. Establish National Amalgam Removal Safety Standards

Develop enforceable safety requirements based on the IABDM PROTECT Protocol, emphasizing applicable OSHA respiratory protection requirements, high-volume evacuation, isolation, ventilation, personal protective equipment, staff training, and informed patient consent.

The PROTECT Protocol is designed to reduce mercury exposure risks for patients, dental professionals, and the environment.

IABDM maintains that protecting dental professionals from mercury exposure is an occupational safety responsibility, not simply a clinical preference. The organization calls for greater awareness of OSHA respiratory protection requirements and consistent safety practices nationwide.

3. Investigate the Casa Pia Trial

Commission an independent investigation examining research ethics, informed consent, safety monitoring, the September 1999 report, and communications with NIH and FDA, while protecting former participants' privacy.

4. Provide Health Assessments for Survivors

Fund voluntary, independent health assessments and appropriate follow-up care for former Casa Pia trial participants, now adults.

International Action and Regulatory Accountability

The European Union began broadly restricting dental amalgam use in January 2025, subject to limited exceptions and transition provisions.

For more than four decades, IABDM has advocated for mercury-free dentistry, biocompatible dental materials, and recognition of the oral-systemic health connection.

Tibau also calls for federal action on FDA Citizen Petition FDA-2025-P-2526 and independent scrutiny of the American Dental Association's (ADA) influence on dental standards of care and regulatory decision-making.

Her appeal raises concerns about how professional standards affect biological dentists advocating for mercury-free dentistry and enhanced safety protocols. Tibau cites disciplinary proceedings involving biological dentist Dr. Blanche Grube as an example warranting examination of how alternative dental approaches are evaluated by licensing boards.

Requested Federal Timeline

Immediately: Preserve Casa Pia research records.

15 days: Designate a federal coordinating official.

30 days: Identify relevant research and regulatory records.

60 days: Develop an interagency action plan.

Tibau requests a written White House response identifying responsible offices and concrete next steps.

IABDM supports transparency, accountability, and stronger protections for patients and dental professionals.

Supporting Documentation

FDA Citizen Petition FDA-2025-P-2526:


Casa Pia FOIA Research Records:

#page=1

About IABDM

Founded in 1984, the International Academy of Biological Dentistry and Medicine is a 501(c)(3) nonprofit advancing biological dentistry through professional education, certification, research initiatives, and its PROTECT Protocol.

IABDM

Samantha Burnell
IABDM
+1 401-578-0274
Visit us on social media:
LinkedIn
Instagram
Facebook

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

IABDM Supports White House Appeal to End Dental Mercury and Investigate Casa Pia Trial News Provided By International Academy of Biological Dentistry and Medicine November 16, 2026, 08:43 GMT Share This Article Distribution channels: Human Rights


EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

MENAFN16112026003118003196ID1111967156


EIN Presswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search